https://omnioncology.net/what-is-the-optimal-approach-to-targeting-braf-v600e-her2-overexpression-and-kras-g12c-in-patients-with-metastatic-crc/ 2026-06-02T13:38:20Z OmniOncology.net en What is the optimal approach to targeting BRAF V600E, HER2 overexpression, and KRAS G12C in patients with metastatic CRC? 2026-06-02T13:38:18Z Blog